Genetic barcoding uncovers the clonal makeup of solid and liquid biopsies and their ability to capture intra-tumoral heterogeneity
Preprint
Abstract
Intra-tumoral heterogeneity (ITH) is fueling tumor progression in breast cancer, as specific clones present within a tumor may have a selective advantage to colonize distant organs and escape therapy. Accurate sampling of ITH is therefore a pressing challenge in clinical oncology, to adequately predict recurrence and inform rational and personalized therapies. Here we used cellular barcoding to track the spatio-temporal composition of human breast cancer clones in six preclinical models – across two cell lines and four patient derived xenografts (PDXs). This allowed direct side-by-side quantitative comparison not only of intra-tumor clonal composition, but also of how that composition was reflected in needle biopsies and cell-free DNA (cfDNA). These analyses highlighted several clinically relevant findings. First, the use of orthogonal genetic and optical barcoding revealed that clonal diversity in the center of non-necrotic primary tumors was significantly higher compared to their periphery. Second, cfDNA barcode analysis suggested that DNA ‘shedding’ in the vasculature varied largely, not only depending on necrosis and tumor burden, but also between models. Third, combining information captured in both solid and liquid biopsies can provide a more robust assessment of tumor clonal composition. Taken together, these results showcases the utility of these barcoded models to optimize the use of solid and liquid biopsies as surrogate markers of ITH.Keywords
All Related Versions
- Published version: Molecular Systems Biology, 22 (5), 659.
This publication has 56 references indexed in Scilit:
- Inferring biologically relevant molecular tissue substructures by agglomerative clustering of digitized spatial transcriptomes with multilayerCell Systems, 2021
- Serial single-cell profiling analysis of metastatic TNBC during Nab-paclitaxel and pembrolizumab treatmentBreast Cancer Research and Treatment, 2020
- Comparison of liquid-based to tissue-based biopsy analysis by targeted next generation sequencing in advanced non-small cell lung cancer: a comprehensive systematic reviewJournal of Cancer Research and Clinical Oncology, 2020
- Intratumor Heterogeneity: The Rosetta Stone of Therapy ResistanceCancer Cell, 2020
- Will traditional biopsy be substituted by radiomics and liquid biopsy for breast cancer diagnosis and characterisation?Medical Oncology, 2020
- The predictive and prognostic significance of liquid biopsy in advanced epidermal growth factor receptor-mutated non-small cell lung cancer: A prospective studyLung Cancer, 2019
- Metastasis as a systemic disease: molecular insights and clinical implicationsBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2019
- Clinical factors associated with circulating tumor DNA (ctDNA) in primary breast cancerMolecular Oncology, 2019
- Chemoresistance Evolution in Triple-Negative Breast Cancer Delineated by Single-Cell SequencingCell, 2018
- Molecular portraits of breast cancer: tumour subtypes as distinct disease entitiesEuropean Journal of Cancer, 2004